Has Jacqueline McCarty, PA received payments from drug or device companies?

Yes. Drug and device makers reported $5,125 in general payments to Jacqueline McCarty, PA across 282 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacqueline McCarty, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacqueline McCarty, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacqueline McCarty, PA

Medical · South Charleston, WVNPI 1295017473

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 24.1% of the total. Among medical clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,125in general payments, 2019–2025

Across 282 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$1K
E.r. Squibb & Sons, L.L.C.$562
Regeneron Healthcare Solutions, Inc.$296
Boehringer Ingelheim$282
Novartis$256
plus $1K from 14 others

What the payments were for

Food & beverage$4,79894%
Education$3276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	84	$1,236
Johnson & Johnson(2 entities)	57	$1,075
E.r. Squibb & Sons, L.L.C.	31	$562
Regeneron Healthcare Solutions, Inc.	11	$296
Boehringer Ingelheim	16	$282
Novartis	13	$256
Lilly USA, LLC	17	$242
Incyte Corporation	6	$173
Galderma Laboratories, L.p.	14	$156
Organon	2	$149
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$132
Dermavant Sciences, Inc.	6	$97
Sanofi	4	$89
Sun Pharmaceutical Industries Inc.	5	$88
Amgen	2	$66
Pfizer	3	$63
LEO Pharma Inc.	3	$59
UCB, Inc.	3	$58
Arcutis Biotherapeutics, Inc.	2	$34
Biofrontera Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUOBRII$127
Sotyktu$108

How this compares

$5,125 in reported general payments places this provider in the 90th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia →

Medicare billing

Part B allowed, 2024

$113,150

Medicare patients

514

Services billed

3,172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	107	$3,169
Fluorouracil	37	$2,363
Triamcinolone Acetonide	137	$1,471
Ketoconazole	73	$1,352
Tretinoin	15	$1,231
Metronidazole	23	$1,167
Fluocinonide	28	$936
Doxycycline Hyclate	63	$913
Mupirocin	116	$775
Clindamycin Phosphate	30	$757
Betamethasone Dipropionate	16	$585
ValacyclovirValacyclovir Hcl	11	$134
Prednisone	13	$30

Paid to pharmacies, not to this prescriber.

Other medical in South Charleston

Katherine BoggsSouth Charleston$46K
Katie CarpenterSouth Charleston$26K
Kellie HanselSouth Charleston$12K
Holli CaragSouth Charleston$7K
Lauren ShafferSouth Charleston$6K
Timothy DouglasSouth Charleston$6K
Anthony KnellSouth Charleston$4K
Kelsey MathisSouth Charleston$3K
Shelley GaumSouth Charleston$2K
Lowell LarewMorgantown$31K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →